Genetic medicine strategies to protect against bioterrorism.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Transactions of the American Clinical and Climatological Association

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 18528482PMCID PMC1500914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Passive Protection against Anthrax by Using a High-Affinity Antitoxin Antibody Fragment Lacking an Fc Region

  2005cited by this paper
• Induction of Protective Immunity to Anthrax Lethal Toxin with a Nonhuman Primate Adenovirus-Based Vaccine in the Presence of Preexisting Anti-Human Adenovirus Immunity

  2005cited by this paper
• Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody.

  2005cited by this paper
• Adenovirus-Based Genetic Vaccines for Biodefense

  2005cited by this paper
• Development of stable liquid formulations for adenovirus-based vaccines.

  2004cited by this paper
• 689. Protection against pulmonary infection with P. aeruginosa following immunization with an adenovirus vector expressing a P. aeruginosa OprF Epitope

  2004cited by this paper
• Adenoviruses as vaccine vectors

  2004cited by this paper
• Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector.

  2004cited by this paper
• Characterization of a Family of Chimpanzee Adenoviruses and Development of Molecular Clones for Gene Transfer Vectors

  2004cited by this paper
• 1015. Induction of Protective Immunity to Anthrax Lethal Toxin with a Chimpanzee Adenovirus-Based Vaccine Carrier in the Presence of Pre-Existing Anti-Human Adenovirus Immunity

  2004cited by this paper
• Human Immunodeficiency Virus Type 1-Specific Immune Responses in Primates upon Sequential Immunization with Adenoviral Vaccine Carriers of Human and Simian Serotypes

  2004cited by this paper
• A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag 1

  2003cited by this paper
• Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

  2003cited by this paper
• Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting

  2003cited by this paper
• Induction of CD8+ T Cells to an HIV-1 Antigen through a Prime Boost Regimen with Heterologous E1-Deleted Adenoviral Vaccine Carriers 1

  2003cited by this paper
• Protective Immunity Evoked Against Anthrax Lethal Toxin After a Single Intramuscular Administration of an Adenovirus-Based Vaccine Encoding Humanized Protective Antigen

  2003cited by this paper
• Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice 1

  2003cited by this paper
• Development of adenovirus serotype 35 as a gene transfer vector.

  2003cited by this paper
• Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier

  2003cited by this paper
• Human antibodies from immunized donors are protective against anthrax toxin in vivo

  2003cited by this paper
• Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

  2003cited by this paper
• Anthrax as a biological weapon, 2002: updated recommendations for management.

  2002cited by this paper
• Efficiency of Protection of Guinea Pigs against Infection with Bacillus anthracis Spores by Passive Immunization

  2002cited by this paper
• Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity

  2002cited by this paper
• Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses.

  2002cited by this paper
• Development of an improved vaccine for anthrax.

  2002cited by this paper
• Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product

  2002cited by this paper
• Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.

  2002cited by this paper
• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

  2002cited by this paper
• Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.

  2001cited by this paper
• Identification of the cellular receptor for anthrax toxin

  2001cited by this paper
• Search for Correlates of Protective Immunity Conferred by Anthrax Vaccine

  2001cited by this paper
• In vitro correlate of immunity in a rabbit model of inhalational anthrax.

  2001cited by this paper
• Bacillus anthracis, a bug with attitude!

  2001cited by this paper
• Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.

  2001cited by this paper
• Passive transfer of protection against Bacillus anthracis infection in a murine model.

  2001cited by this paper
• Replication-Defective Vector Based on a Chimpanzee Adenovirus

  2001cited by this paper
• Gene therapy : therapeutic mechanisms and strategies

  2000cited by this paper
• Understanding Bacillus anthracis pathogenesis.

  1999cited by this paper
• Germination of Bacillus anthracis spores within alveolar macrophages

  1999cited by this paper
• Variability of Human Systemic Humoral Immune Responses to Adenovirus Gene Transfer Vectors Administered to Different Organs

  1999cited by this paper
• Immune responses to adenovirus and adeno-associated virus in humans

  1999cited by this paper
• Development of porcine adenovirus-3 as an expression vector.

  1999cited by this paper
• Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.

  1999cited by this paper
• Ovine Adenovirus Vectors Overcome Preexisting Humoral Immunity against Human Adenoviruses In Vivo

  1999cited by this paper
• Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors.

  1998cited by this paper
• Immune Response to Recombinant Capsid Proteins of Adenovirus in Humans: Antifiber and Anti-Penton Base Antibodies Have a Synergistic Effect on Neutralizing Activity

  1998cited by this paper
• Impact of Preexisting and Induced Humoral and Cellular Immune Responses in an Adenovirus-Based Gene Therapy Phase I Clinical Trial for Localized Mesothelioma

  1998cited by this paper
• High efficiency adenovirus-mediated gene transfer to human dendritic cells.

  1998cited by this paper
• Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs

  1997cited by this paper
• The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus

  1997cited by this paper
• Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity

  1997cited by this paper
• Adenoviruses as gene-delivery vehicles.

  1996cited by this paper
• A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

  1996cited by this paper
• Recombinant adenoviruses as vaccines.

  1995cited by this paper
• Anthrax protective antigen forms oligomers during intoxication of mammalian cells.

  1994cited by this paper
• Gene therapy: adenovirus vectors.

  1993cited by this paper
• A recombinant human adenovirus vaccine against rabies.

  1990cited by this paper
• Harrison's Principles of Internal Medicine

  1988cited by this paper
• Demonstration of a capsule plasmid in Bacillus anthracis

  1985cited by this paper
• Evidence for plasmid-mediated toxin production in Bacillus anthracis

  1983cited by this paper
• Neutralizing antibodies against 33 human adenoviruses in normal children in Rome

  1982cited by this paper
• Characterization of four new adenovirus serotypes isolated from chimpanzee tissue explants.

  1971cited by this paper
• SUCCESSFUL TREATMENT OF RHESUS MONKEYS FOR SEPTICEMIA ANTHRAX.

  1964cited by this paper
• Large-Scale Production of Protective Antigen of Bacillus anthracis in Anaerobic Cultures

  1963cited by this paper
• STUDIES ON IMMUNITY IN ANTHRAX X

  1963cited by this paper
• Journal of Immune Based Therapies and Vaccines Human Anti-anthrax Protective Antigen Neutralizing Monoclonal Antibodies Derived from Donors Vaccinated with Anthrax Vaccine Adsorbed

  year unknowncited by this paper

• Genetic Modification of the Lung Directed Toward Treatment of Human Disease

  2017cites this paper
• Bioterrorism: The Role of Genetics and Molecular Biology

  2017cites this paper
• Adenovirus: The First Effective In Vivo Gene Delivery Vector

  2014cites this paper
• Phylogenetic analysis and victim contact tracing of rabies virus from humans and dogs in Bali, Indonesia

  2013cites this paper
• Delivery of antigens by viral vectors for vaccination.

  2011cites this paper
• President's address: thinking about the unthinkable.

  2011cites this paper